Prelude Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-27,511	Closed	-$593K	–	1121
2025 Q2	$593K	Buy	+27,511	New	+$511K	0.06%	388
2024 Q1	–	Sell	-16,595	Closed	-$520K	–	1285
2023 Q4	$520K	Buy	16,595 +5,727	+53%	+$137K	0.05%	495
2023 Q3	$226K	Buy	+10,868	New	+$295K	0.02%	832
2020 Q3	–	Sell	-362	Closed	-$18K	–	1763
2020 Q2	$18K	Buy	+362	New	+$17.4K	﹤0.01%	1404
2020 Q1	–	Sell	-884	Closed	-$38K	–	1372
2019 Q4	$38K	Buy	+884	New	+$38.5K	﹤0.01%	1434
2019 Q3	–	Sell	-1,355	Closed	-$36K	–	1669
2019 Q2	$36K	Sell	1,355 -584	-30%	-$14.9K	﹤0.01%	1190
2019 Q1	$52K	Buy	+1,939	New	+$45.3K	0.01%	1111
2018 Q3	–	Hold	0	–	–	–	1701
2018 Q2	–	Hold	0	–	–	–	1618
2017 Q3	–	Hold	0	–	–	–	1587
2017 Q2	–	Hold	0	–	–	–	1568
2016 Q4	–	Hold	0	–	–	–	1511
2016 Q3	–	Hold	0	–	–	–	1561
2014 Q1	–	Sell	-23,020	Closed	-$575K	–	1823
2013 Q4	$575K	Hold	23,020	–	–	0.11%	302
2013 Q3	$632K	Sell	23,020 -34,980	-60%	-$731K	0.15%	236
2013 Q2	$1.05M	Buy	+58,000	New	+$799K	0.3%	97